Ecopipam Tablets to Study Tourette's Syndrome in Children and Adolescents
Clinical trial NCT04007991 · COMPLETED
Trial details
- NCT number
- NCT04007991
- Sponsor
- Emalex Biosciences Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-28
- Primary completion
- 2021-09-23
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.